HC Wainwright Reaffirms Buy Rating for Beam Therapeutics (NASDAQ:BEAM)
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright ...
ETF Daily News3 天
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Bought by Charles Schwab Investment Management Inc.
It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP ...
manilatimes5 天
Qualifacts and Catholic Charities Boston Family Counseling and Guidance Center Partner to ...
Catholic Charities Boston seeks to improve efficiency, client satisfaction, and financial performance with Qualifacts' InSync EHR and RCMS+ solution. Nashville, Tenn. & Boston, Mass., Dec. 05, 2024 ...